Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
http://www.uniindia.com/news/business-economy/pharma-agreement-srim/2224527.html
Anybody know whether it's possible to create a new buyback programme and if so what it would take? i.e BOD approval, shareholder approval or approval from the Jersey authorities?
A rough calculation suggests they must be getting pretty close to the $9.9m they raised by selling U308.
It's not clear to me that they can just sell more U308 and continue buying shares from reading the announcement of the buyback programme "These funds will enable the Company to conduct an enlarged share buyback programme to purchase up to US$10 million of the Company's outstanding Ordinary Shares, pursuant to the authority the Company has in place to make market acquisitions in accordance with the Jersey Companies Law (the "Existing Authority"). The Existing Authority permits the purchase of a maximum of 8,821,572 Ordinary Shares at a maximum price (excluding expenses) of 105 per cent of the average market value of an Ordinary Share as derived from the AIM Appendix to the London Stock Exchange Daily Official List for the five business days immediately preceding the date of purchase."
Any thoughts appreciated.
Trendz, I would imagine they will give a trading update with the interim announcement which according to their financial calendar is in September/October 2020. So pretty soon I would think.
I'm presuming Countrywide Surveying Services are part of CWD. I'm afraid I don't know much about CWD even though I'm a shareholder!
https://www.mortgageintroducer.com/has-normal-service-resumed/
>Stop using Zoopla data for listing info
Keepit, the advantage of Zoopla is that it's easy to follow PB's daily instructions to give you an approximation of what is going on. The last time I looked at Rightmove the listings were spread over multiple regions.
Rightmove would be better for an overall view of the market but even they don't list all agents. For my proxy of PB's market share I adjust the figure based on the number of property listings compared to Rightmove (albeit that adjustment figure was factored in a couple of years ago).
Like I say. Just a proxy but I think pretty close to the truth and good for comparing growth (or lack of it :) ) even if actual numbers aren't 100% accurate. It's been very useful over the years and I strongly believe it gives me an advantage over the average investor.
Don't worry. Sain's been passing comment on here for a few years now and it didn't stop the SP rising up to £5+. :)
Not sure people commenting makes any difference whatsoever.
I've been tracking PB's listings for a few years now and Estate Agents generally doing very well at the moment. PB's recent performance not exceptional and the big question is how long will it last?
I think if you look back at PB's UK profits over the years you'll find a max operating profit of about £4m in there somewhere. Unlikely to match the number of instructions they had back then this financial year but they have been increasing the average revenue per instruction and fee. Market share lower than last year at the same time according to my proxy which uses the total number of daily listings on Zoopla. The number of LPEs lower.
The fact that these shares rose to £5+ and were worth nowhere near that amount even when growth in instructions and market share was very impressive shows you there's no limit to what investors will pay so I'll never disagree with anybody saying the SP will reach such and such a level but it would be nice to see those comments backed up with reasoning.
>I'm not fully up to speed with all the MM tricks but those quotes, I guess, could suggest they want to fill a large order i.e. don't want to sell to PI's but keen to obtain shares for as little as they can?
I struggle to fully understand what market makers are obliged to do and what they get up to. So you could well be right.
I picked up a few early doors yesterday between 51p & 52p from memory. Then again the asking price rose significantly.
Just looking back to April 2017 when BXP @ 69.5p. BXPHARMA @ 120 in their own currency. Now at 113.7 in their own currency.
Pharma,
>I'm not sure if the movement we've seen today on the LSE simply reflects the large increases we're seeing on the DSE, or whether we have a GDR buyer in the background, that MMs are attempting to fill?
Only 10429 shares trades today and 5429 of them was me. Wanted more but not paying 58p if the spread is effectively 5.5p.
We need somebody to report on the unusually high discount to the Dhaka SP and that spread to close.
Up another 5% or so in Dhaka on high and increasing volume.
https://www.amarstock.com/interactive-chart?symbol=BXPHARMA
July the best month ever for instructions according to my proxy. I imagine they are operating with fewer LPEs than when the last records were set too.
Looks like the whole sector doing well.
Losses from the UK in the 2020 FY I should think. Reduced losses as a group though.
Hard to guess how the market will take all this news. Do your own research.
https://www.dhakatribune.com/bangladesh/2020/07/22/beximco-pharma-exports-covid-19-drug-remdesivir
The Australian mining stocks followed suit last night and posted significant gains on the whole. https://twitter.com/bestofasx/status/1285135899248848897/photo/1
Hard to understand why the enthusiasm hasn't spilled over into YCA this morning given the 20%+ discount to NAV at a Uranium spot price of $32.6. If the miners and explorers are going to make money then the U price needs to be $40+. More like $45 to $50. Some bulls still talking about $70.
The Canadian equivalent of YCA, Uranium Participation Corp, trading as U in Toronto has a discount to NAV of only 5% according to an analysis I read dated July 16th and YCA are buying their own shares in the market.
Anybody have any thoughts as to why the SP not doing much?
A big day for uranium shares traded in the USA today. Cameco, the bellwether uranium mining share up about 10% on the week and 5% today on the Toronto stock exchange.
I got a bit excited when I saw YCA shares trading up 17.65% in the USA as an 'over the counter' stock but then saw it was only 100 shares at a price of $3 (about £2.40).
TD securities suggesting it's down to Presidential candidate Joe Biden making comments suggesting nuclear power is part of a $2 Trillion plan for climate change. https://twitter.com/UraniumEquities/status/1284175720986693632/photo/1
A volume of around 100,000 shares has moved the SP up about 2.7% this morning.
Yesterday, starting just after 11am, YCA bought 90,000 of their own shares https://www.lse.co.uk/rns/YCA/transaction-in-own-shares-re5raj436tw9dlp.html and have a $10m fund (less what they've already spent) for buying more if the shares are below their NAV/S.
Been buying myself this morning. Do your own research.
>No material impact to guidance.... interesting. Kicking the can down the road?
Suggests to me they were deliberately limiting output. I enjoy listening to Brandon Munro when interviewed for Crux Investor. Clearly not impartial and would love the price of Uranium to rise but good to know the bull arguments.
Reading between the lines of those interviews there does appear to be a suggestion that KAZ are becoming more astute and thinking about the pricing for their long term contracts with the utilities. I'm also reading between the lines and thinking Cameco are in no hurry to bring capacity back, putting more pressure on the utilities to enter into favourable long term deals.
All very interesting but perhaps I've misinterpreted what Brandon might be suggesting. People should do their own research.
I reckon there's still about a 25% discount to NAV for YCA despite the recent SP rise.